These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18854981)

  • 1. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin.
    Chen YM; Guo LH
    Arch Toxicol; 2009 Mar; 83(3):255-61. PubMed ID: 18854981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive binding of Chlorin p6 and Dansyl-l-Proline to Sudlow's site II of human serum albumin.
    Patel S; Sharma KK; Datta A
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():925-31. PubMed ID: 25456656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined fluorescence and electrochemical investigation on the binding interaction between organic acid and human serum albumin.
    Chen YM; Guo LH
    J Environ Sci (China); 2009; 21(3):373-9. PubMed ID: 19634451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of energies and sites of binding of PFOA and PFOS to human serum albumin.
    Salvalaglio M; Muscionico I; Cavallotti C
    J Phys Chem B; 2010 Nov; 114(46):14860-74. PubMed ID: 21028884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkane sulfonyl fluorides non-covalently bind to human serum albumin at Sudlow's sites.
    Jin Z; Chi M; He Q; Pan Y; Sun C
    Toxicol Lett; 2019 Feb; 301():17-23. PubMed ID: 30408508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomer-Specific Binding Affinity of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) to Serum Proteins.
    Beesoon S; Martin JW
    Environ Sci Technol; 2015 May; 49(9):5722-31. PubMed ID: 25826685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural evidence of perfluorooctane sulfonate transport by human serum albumin.
    Luo Z; Shi X; Hu Q; Zhao B; Huang M
    Chem Res Toxicol; 2012 May; 25(5):990-2. PubMed ID: 22482699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of perfluorooctanoic acid and perfluorooctanesulfonic acid with serum albumins by native mass spectrometry, fluorescence and molecular docking.
    Chi Q; Li Z; Huang J; Ma J; Wang X
    Chemosphere; 2018 May; 198():442-449. PubMed ID: 29425944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of perfluoroalkyl substances on neurosteroid synthetic enzymes in the rat.
    Xu R; Shen Q; Li S; Li X; Li H; Lü Y; Lian QQ; Ge RS
    Chem Biol Interact; 2017 Jun; 272():182-187. PubMed ID: 28535922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.
    Okabe N; Hashizume N
    Biol Pharm Bull; 1994 Jan; 17(1):16-21. PubMed ID: 8148809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual binding of a potential biomarker with human serum albumin.
    De D; Kaur H; Datta A
    Chem Asian J; 2013 Apr; 8(4):728-35. PubMed ID: 23404770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy.
    D'eon JC; Simpson AJ; Kumar R; Baer AJ; Mabury SA
    Environ Toxicol Chem; 2010 Aug; 29(8):1678-88. PubMed ID: 20821619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of novel fluorinated alternatives to long-chain perfluoroalkyl substances to human liver cell line and their binding capacity to human liver fatty acid binding protein.
    Sheng N; Cui R; Wang J; Guo Y; Wang J; Dai J
    Arch Toxicol; 2018 Jan; 92(1):359-369. PubMed ID: 28864880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding sites of fluorescent probes on human serum albumin.
    Muller N; Lapicque F; Drelon E; Netter P
    J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorooctanoic acid and perfluorooctane sulfonate in two fish species collected from the Roter Main River, Bayreuth, Germany.
    Becker AM; Gerstmann S; Frank H
    Bull Environ Contam Toxicol; 2010 Jan; 84(1):132-5. PubMed ID: 19946664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper.
    Suja F; Pramanik BK; Zain SM
    Water Sci Technol; 2009; 60(6):1533-44. PubMed ID: 19759456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry.
    Maestri L; Negri S; Ferrari M; Ghittori S; Fabris F; Danesino P; Imbriani M
    Rapid Commun Mass Spectrom; 2006; 20(18):2728-34. PubMed ID: 16915561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs.
    Sanchez Garcia D; Sjödin M; Hellstrandh M; Norinder U; Nikiforova V; Lindberg J; Wincent E; Bergman Å; Cotgreave I; Munic Kos V
    Chem Biol Interact; 2018 Feb; 281():1-10. PubMed ID: 29248446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of PFOA and PFOS in male rats during a subchronic exposure.
    Cui L; Liao CY; Zhou QF; Xia TM; Yun ZJ; Jiang GB
    Arch Environ Contam Toxicol; 2010 Jan; 58(1):205-13. PubMed ID: 19468665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.